Fall 2020 Vol. 10 Issue 03
-
From the Editor-in-Chief
Cancer in Minority PopulationsPaying attention to the social determinants of health will promote greater equity in cancer outcomes for all.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
Setting BoundariesHonor your own needs to establish a strong foundation for healing.
by Hester Hill Schnipper
-
Caregiving With Confidence
Finding the Middle GroundNot all patients follow doctors' orders, which can be frustrating for their caregivers.
by Karen J. Bannan
-
Policy Matters
The E-Cigarette Regulatory LandscapeThe FDA is taking several steps to restrict and reduce e-cigarette use among youth.
by Carmine S. Leggett, PhD
-
Learning Medicare’s ABCDs
Medicare was established to help provide affordable health care coverage for older Americans. But Medicare beneficiaries with cancer can still face financial burdens related to their care.
by Kate Yandell
-
More Choices to Treat Lung Cancer
Advances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer. But having a wider selection of therapies to choose from can make treatments more complex.
by Kendall K. Morgan
-
Worth the Wait
Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.
by Sharon Tregaskis
-
Survivor Profile
An Unlikely PivotMedha Deoras-Sutliff's experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers.
by Lindsey Konkel
-
Q&A
The Lost Poetry of Patient StoriesMedical histories capture a vital snapshot of a patient's health status. In his new book, hematologist-oncologist Mikkael A. Sekeres provides a richer narrative.
by Marci A. Landsmann
-
Sound Advice
Your Questions, Our AnswersExperts offer advice on making caregiving work, the challenges of telemedicine, and absent friends.
-
Get Involved
Patients With PetsA helping hand for pet owners receiving cancer treatment.
by Jackie Oshiro
-
Facts and Stats
A Brief History of Checkpoint InhibitorsThe advent of checkpoint inhibitors has broadened the range of cancer patients able to take advantage of immunotherapy.
by Bradley Jones
Most pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.
by Taneia Surles
Understanding How High and Low Testosterone Levels Can Treat Prostate CancerUsing high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
Financial Screenings for People with CancerCancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst